Sy Co., Ltd. (KOSDAQ:109610)
2,000.00
-90.00 (-4.31%)
At close: Jul 16, 2026
Sy Co., Ltd. Revenue
Sy Co., Ltd. had revenue of 126.30B KRW in the quarter ending March 31, 2026, with 8.60% growth. This brings the company's revenue in the last twelve months to 511.55B, down -5.15% year-over-year. In the year 2025, Sy Co., Ltd. had annual revenue of 501.55B, down -10.60%.
Revenue (ttm)
511.55B
Revenue Growth
-5.15%
P/S Ratio
0.19
Revenue / Employee
1.55B
Employees
329
Market Cap
95.52B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 501.55B | -59.46B | -10.60% |
| Dec 31, 2024 | 561.01B | 7.34B | 1.33% |
| Dec 31, 2023 | 553.67B | 16.47B | 3.07% |
| Dec 31, 2022 | 537.20B | 113.10B | 26.67% |
| Dec 31, 2021 | 424.10B | 114.03B | 36.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DASAN Networks | 547.21B |
| Se Gyung Hi Tech | 285.00B |
| Meta Biomed | 99.67B |
| OPTUS Pharmaceutical | 91.62B |
| Finger | 91.45B |
| Hana Technology | 87.75B |
| Codes Combine | 41.14B |
| Vuno Inc. | 33.36B |